Menu

Timber Pharmaceuticals, Inc. TMBR

Full chart Compare
Set alert

Price alert · TMBR

All alert types
0.34 0.00 (+0.00%)

Nov 28, 2023, 3:59 PM EST

0.3202 Day range 0.35

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $92.00KExpenses → Selling, General & Admin: $6.02MExpenses → Research & Development: $13.30MExpenses → Interest Expense: $228.46KExpenses → Income Tax: $7.60KGross Profit → Expenses: $83.18KRevenue → Gross Profit: $83.18KNet Loss → Expenses: $19.38MOther Income$92.00KGross Profit$83.18KNet Loss$19.38MExpenses$19.55MSelling, General & Admin$6.02MResearch & Development$13.30MInterest Expense$228.46KIncome Tax$7.60KRevenue$83.18K

Latest period ending Dec 31, 2022 · select a line to chart its full history

TMBR annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Jan 31, 2020FY 2018 Jan 31, 2019
83.18K886.53K453.81K057.00K
83.18K886.53K453.81K0-26.00K
-19.24M-10.65M-20.21M-9.69M-16.51M
-19.38M-10.64M-15.12M-9.69M-17.26M
-9.19-13.31-48.50-450.00-1,338.00
TMBR annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Jan 31, 2020FY 2018 Jan 31, 2019
9.21M16.94M10.46M—3.07M
10.28M17.90M11.63M—3.65M
5.04M4.63M2.11M—2.36M
1.75M368.92K617.23K—0
5.23M13.27M7.61M—1.30M
TMBR annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Jan 31, 2020FY 2018 Jan 31, 2019
-15.85M-9.31M-8.29M-10.11M-14.99M
-7.08K-17.80K-2.66M-30.00K-43.00K
8.13M15.79M21.24M7.79M10.53M
-7.08K-17.80K0-30.00K-43.00K
-7.73M6.46M10.29M-2.34M-4.51M